Royal Bank of Canada Lowers WELL Health Technologies (TSE:WELL) Price Target to C$7.50

WELL Health Technologies (TSE:WELL) had its price objective reduced by Royal Bank of Canada from C$8.50 to C$7.50 in a report released on Monday morning,BayStreet.CA reports. They currently have an outperform rating on the stock.

Several other equities research analysts have also recently issued reports on the stock. Scotiabank raised their target price on shares of WELL Health Technologies from C$6.00 to C$7.00 in a research report on Monday, December 16th. Raymond James lifted their price target on shares of WELL Health Technologies from C$10.00 to C$11.00 in a report on Tuesday, December 17th. Haywood Securities upped their price objective on WELL Health Technologies from C$8.00 to C$10.00 in a report on Friday, December 13th. CIBC lifted their target price on WELL Health Technologies from C$5.25 to C$7.00 in a report on Friday, December 13th. Finally, Ventum Financial upped their price target on WELL Health Technologies from C$7.50 to C$8.00 in a research note on Thursday, January 30th.

WELL Health Technologies Stock Up 2.3 %

Shares of TSE:WELL opened at C$4.43 on Monday. The company has a current ratio of 1.14, a quick ratio of 1.02 and a debt-to-equity ratio of 46.79. The firm has a market cap of C$1.11 billion, a price-to-earnings ratio of 15.01, a PEG ratio of -1.93 and a beta of 1.20. The stock’s 50-day moving average price is C$5.68 and its two-hundred day moving average price is C$5.58. WELL Health Technologies has a 12-month low of C$3.41 and a 12-month high of C$7.36.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.